Literature DB >> 17620454

Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.

Feng Guo1, Debra Weih, Elke Meier, Falk Weih.   

Abstract

Nuclear factor-kappaB (NF-kappaB) plays a crucial role in B-cell and lymphoid organ development. Here, we studied the consequences of constitutive, signal-independent activation of the alternative NF-kappaB pathway for the splenic marginal zone (MZ). In contrast to nfkb2(-/-) mice, which lack both p100 and p52, mice that lack only the inhibitory p100 precursor but still express the p52 subunit of NF-kappaB2 (p100(-/-)) had markedly elevated MZ B-cell numbers. Both cell-intrinsic mechanisms and increased stromal expression of vascular cell adhesion molecule-1 (VCAM-1) contributed to the accumulation of MZ B cells in p100(-/-) spleens. While migration of p100(-/-) MZ B cells toward the lysophospholipid sphingosine-1 phosphate (S1P) was not affected, CXCL13-stimulated chemotaxis was impaired, correlating with reduced migration of MZ B cells into follicles in response to lipopolysaccharide (LPS). Strikingly, p100 deficiency resulted in the absence of a normal marginal sinus, strongly induced expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and glycosylated cell adhesion molecule-1 (GlyCAM-1), and the formation of nonfunctional ectopic high endothelial venule (HEV)-like structures in the red pulp. Thus, constitutive activation of the alternative NF-kappaB pathway favors MZ B-cell development and accumulation but leads to a disorganized spleen microarchitecture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620454     DOI: 10.1182/blood-2007-02-075143

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

2.  Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Authors:  Shaun Rosebeck; Lisa Madden; Xiaohong Jin; Shufang Gu; Ingrid J Apel; Alex Appert; Rifat A Hamoudi; Heidi Noels; Xavier Sagaert; Peter Van Loo; Mathijs Baens; Ming-Qing Du; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Science       Date:  2011-01-28       Impact factor: 47.728

Review 3.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

4.  BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.

Authors:  D Lisak; T Schacht; A Gawlitza; P Albrecht; O Aktas; B Koop; M Gliem; H H Hofstetter; K Zanger; G Bultynck; J B Parys; H De Smedt; T Kindler; P Adams-Quack; M Hahn; A Waisman; J C Reed; N Hövelmeyer; A Methner
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

5.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

6.  Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.

Authors:  Sinyi Kong; Hongxin Dong; Jianxun Song; Muthusamy Thiruppathi; Bellur S Prabhakar; Quan Qiu; Zhenghong Lin; Eduardo Chini; Bin Zhang; Deyu Fang
Journal:  J Immunol       Date:  2015-09-16       Impact factor: 5.422

7.  Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells.

Authors:  Nilushi S De Silva; Kathryn Silva; Michael M Anderson; Govind Bhagat; Ulf Klein
Journal:  J Immunol       Date:  2016-02-05       Impact factor: 5.422

8.  TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.

Authors:  Gema Pérez-Chacón; David Llobet; Constanza Pardo; José Pindado; Yongwon Choi; John C Reed; Juan M Zapata
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

9.  RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.

Authors:  Jingjing Xu; Peng Zhou; Wenjuan Wang; Aining Sun; Feng Guo
Journal:  J Mol Med (Berl)       Date:  2013-09-17       Impact factor: 4.599

Review 10.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.